Insulin resistance contributes to racial disparities in breast cancer prognosis in US women
Emily J. Gallagher(Icahn School of Medicine at Mount Sinai), Nina A. Bickell(Center for Health and Gender Equity), Derek LeRoith(Icahn School of Medicine at Mount Sinai), Daliz Cruz(Center for Health and Gender Equity), Brigid K. Killelea(Yale University), Lydia Choi(Wayne State University), Anupma Nayak(University of Pennsylvania), Kezhen Fei(Center for Health and Gender Equity), Tari A. King(Brigham and Women's Hospital), Melissa Pilewskie(University of Michigan), Elisa Port(Icahn School of Medicine at Mount Sinai), Rebeca Franco(Center for Health and Gender Equity), Neil B. Friedman(Mercy Medical Center), Irini Markella Antoniou(Icahn School of Medicine at Mount Sinai), Sheldon Feldman(Columbia College), Susan K. Boolbol(Poughkeepsie Public Library District)
Cited by 64
Related Papers
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
|Cancer Discovery|2021|241
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
|Journal of Clinical Investigation|2018|200
Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis
|Cancer Discovery|2019|184
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
|Nature Genetics|2015|166
Leptin Improves Insulin Resistance and Hyperglycemia in a Mouse Model of Type 2 Diabetes
|Endocrinology|2005|104